/

Other

/

Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc.

Verified Nov 2026

Other

·

United States flag

Plano, Texas

·

Since 2002

Reata Pharmaceuticals is a biopharmaceutical company founded in 2002 and headquartered in Plano, Texas, with 200–500 employees. The company develops treatments for kidney disease, liver disease, and autoimmune conditions. In May 2026, Biogen completed a $7.1 billion acquisition of Reata, integrating its drug development capabilities into Biogen's portfolio. Reata serves healthcare providers and medical institutions managing serious diseases.

Reata Pharmaceuticals, Inc.

Verified Nov 2026

AT A GLANCE

Founded

2002

Headquarters

United States flag

Plano, Texas

Employees

200-500

Ownership

Reata Pharmaceuticals, Inc. at a glance

Employees

200-500

Founded

2002

Headquarters

Plano, Texas

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Reata Pharmaceuticals is a biopharmaceutical company founded in 2002 and headquartered in Plano, Texas, with 200–500 employees. The company develops treatments for kidney disease, liver disease, and autoimmune conditions. In May 2026, Biogen completed a $7.1 billion acquisition of Reata, integrating its drug development capabilities into Biogen's portfolio. Reata serves healthcare providers and medical institutions managing serious diseases.

At a glance

Attribute

Detail

Founded

2002

Headquarters

Plano, Texas

Employees

200-500

What Reata Pharmaceuticals, Inc. makes

Reata develops treatments through molecular pathway targeting, with omaveloxolone approved for Friedreich's ataxia and serialization compliance implemented for DSCSA and EU FMD regulations.

Latest developments

Facilities

Reata Pharmaceuticals, Inc. is headquartered in Plano, Texas. Public sources also reference these locations:

Company details

The company operates a facility in Irving, Texas, and now operates as part of Biogen following the 2026 acquisition. Reata Pharmaceuticals, Inc. was founded in 2002, has an estimated 200-500 employees, and is headquartered in Plano, Texas.

Frequently asked questions

What does Reata Pharmaceuticals, Inc. do?

Reata Pharmaceuticals is a biopharmaceutical company founded in 2002 and headquartered in Plano, Texas, with 200–500 employees. The company develops treatments for kidney disease, liver disease, and autoimmune conditions. In May 2026, Biogen completed a $7.1 billion acquisition of Reata, integrating its drug development capabilities into Biogen's portfolio. Reata serves healthcare providers and medical institutions managing serious diseases.

Where is Reata Pharmaceuticals, Inc. headquartered?

Reata Pharmaceuticals, Inc. is headquartered in Plano, Texas (5320 Legacy Drive, Plano, Texas, 75024).

When was Reata Pharmaceuticals, Inc. founded?

Reata Pharmaceuticals, Inc. was founded in 2002.

How big is Reata Pharmaceuticals, Inc.?

Reata Pharmaceuticals, Inc. has an estimated 200-500 employees.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Plano, Texas (HQ)Headquarters · United States
Plano, Texas (HQ)5320 Legacy Drive, Plano, Texas, 75024, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.